Related Experiment Video
Updated: Jun 15, 2026
09:43
Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
Published on: January 14, 2014
8.4K
The source of IDH-mutant gliomas
Christopher W Mount1,2,3, Mario L Suvà1,2,3
1Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Science (New York, N.Y.)
|January 8, 2026
Summary
Deep sequencing of human brain tissue identified the likely cell origin for isocitrate dehydrogenase (IDH)-mutant gliomas. This finding advances understanding of these common brain tumors.
Area of Science:
- Neuro-oncology
- Genomics
- Cancer Biology
Background:
- IDH-mutant gliomas are common brain tumors.
- The cell of origin for these tumors remains uncertain.
- Understanding the cell of origin is crucial for developing targeted therapies.
Purpose of the Study:
- To identify the specific cell type in the human brain that gives rise to IDH-mutant gliomas.
- To provide insights into the early molecular events driving glioma development.
Main Methods:
- Whole-genome sequencing of human brain tissue samples from IDH-mutant glioma patients.
- Comparative analysis of tumor DNA and matched normal brain DNA.
- Bioinformatic analysis to identify mutations and cellular origins.
Main Results:
- Deep sequencing revealed specific genetic alterations characteristic of a particular glial cell lineage.
- The study pinpoints a probable cell of origin for IDH-mutant gliomas.
- Identification of early mutational events within the proposed cell of origin.
Conclusions:
- The findings suggest a specific glial cell type as the likely progenitor of IDH-mutant gliomas.
- This discovery offers a critical foundation for future research into glioma pathogenesis.
- Understanding the cell of origin may pave the way for novel diagnostic and therapeutic strategies.
Related Concept Videos
03:18Non-LTR Retrotransposons
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...